Finanzwire Finanzwire
Basculer en Français
10936 Companies
238806 Keywords
167668 Articles
128366 Press releases
Headlines Articles Press releases CROSSJECT Remove
  1. Home
  2. Companies
  3. CROSSJECT
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 06/04/2024 at 19:30, 2 years 3 months ago

    Crossject announces highly successful closing of its €8 million rights offering

    Crossject successfully closes €8 million rights offering, securing funding for ZEPIZURE® development and FDA approval. Gemmes Venture remains a key supporter
    FDA Approval Rights Offering Crossject ZEPIZURE® Gemmes Venture
    Logo of CROSSJECT
  • BRIEF

    published on 05/30/2024 at 10:35, 2 years 3 months ago

    Crossject: Publication of Clinical Data on ZEPIZURE®

    Crossject ZEPIZURE® Neurology And Therapy Midazolam Needle-free Injection
  • PRESS RELEASE

    published on 05/30/2024 at 10:30, 2 years 3 months ago

    Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy

    Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability
    Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector
    Logo of CROSSJECT
Previous page
1 ... 5 6
Accesswire
  • Published on 09/05/2026 at 04:05, 3 hours 25 minutes ago

    Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update

  • Published on 09/04/2026 at 23:30, 8 hours ago

    FutureGen Industries Announces Shares for Debt Settlement

  • Published on 09/04/2026 at 23:00, 8 hours 30 minutes ago

    Golden Minerals Announces Management Change and Argentine Project Update

  • Published on 09/04/2026 at 22:30, 9 hours ago

    Panther Minerals Closes Brokered Private Placement of $3,000,000

  • Published on 09/04/2026 at 14:30, 17 hours ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/04/2026 at 22:10, 9 hours 19 minutes ago

    Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference

  • Published on 09/04/2026 at 19:20, 12 hours 9 minutes ago

    Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026

  • Published on 09/04/2026 at 18:55, 12 hours 35 minutes ago

    Holding(s) in Company

  • Published on 09/04/2026 at 18:50, 12 hours 39 minutes ago

    A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset

  • Published on 09/04/2026 at 18:05, 13 hours 24 minutes ago

    Grundig Unveils New Product Lineup at IFA 2026, Marking a New Phase in Strategic Partnership

View all EQS
Les Echos
  • Published on 09/04/2026 at 18:57, 12 hours 33 minutes ago

    Disclosure of transactions in own shares from September 1 to September 4, 2026

  • Published on 09/04/2026 at 17:45, 13 hours 45 minutes ago

    Declaration of voting rights at the end of August 2026

  • Published on 09/04/2026 at 17:45, 13 hours 45 minutes ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 09/04/2026 at 16:00, 15 hours 30 minutes ago

    Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026

  • Published on 09/04/2026 at 16:00, 15 hours 30 minutes ago

    Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy